Shanghai Xuerong Biotechnology Co.,Ltd.

XSEC:300511 Stock Report

Market Cap: CN¥2.0b

Shanghai Xuerong BiotechnologyLtd Past Earnings Performance

Past criteria checks 0/6

Shanghai Xuerong BiotechnologyLtd's earnings have been declining at an average annual rate of -56%, while the Food industry saw earnings growing at 2.5% annually. Revenues have been growing at an average rate of 4.7% per year.

Key information

-56.0%

Earnings growth rate

-55.7%

EPS growth rate

Food Industry Growth7.2%
Revenue growth rate4.7%
Return on equity-17.2%
Net Margin-9.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shanghai Xuerong BiotechnologyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300511 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,263-2241094
30 Jun 242,261-3731665
31 Mar 242,327-4062206
31 Dec 232,565-1882437
30 Sep 232,615-4212788
30 Jun 232,722-1452278
31 Mar 232,587-1221638
01 Jan 232,320-2871397
30 Sep 222,293-1901667
30 Jun 222,118-3421389
31 Mar 222,083-35615211
01 Jan 222,073-31215314
30 Sep 212,068-8517115
30 Jun 212,1352119914
31 Mar 212,16817917214
31 Dec 202,20224717612
30 Sep 202,20832715612
30 Jun 202,07726014011
31 Mar 202,02925414711
31 Dec 191,96522013011
30 Sep 191,86112811012
30 Jun 191,92323610911
31 Mar 191,84117611512
31 Dec 181,84715111811
30 Sep 181,84117412010
30 Jun 181,66811310613
31 Mar 181,61018610010
31 Dec 171,3301221007
30 Sep 171,124156825
30 Jun 171,044133960
31 Mar 17985101890
31 Dec 16999105850
30 Sep 161,027142850
30 Jun 161,048148910
31 Mar 161,060154920
31 Dec 151,019123960
31 Dec 1488895930
31 Dec 1377379910

Quality Earnings: 300511 is currently unprofitable.

Growing Profit Margin: 300511 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300511 is unprofitable, and losses have increased over the past 5 years at a rate of 56% per year.

Accelerating Growth: Unable to compare 300511's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 300511 is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (-5.8%).


Return on Equity

High ROE: 300511 has a negative Return on Equity (-17.22%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies